Cargando…
Nationwide pharmacovigilance data for cetuximab-induced anaphylaxis and predictive model validation using prospective specific IgE detection
BACKGROUND: Cetuximab (chimeric monoclonal antibody to human epidermal growth factor receptor) is used to treat colorectal and head and neck cancers. Due to cross-reactivity with galactose-α-1,3-galactose (alpha-gal), it can induce hypersensitivity even at first administration. We aimed to determine...
Autores principales: | Park, Kyung Hee, Lee, Jongsun, Beom, Seung Hoon, Shin, Sang Joon, Ahn, Joong Bae, Kim, Sung-Ryeol, Lee, Jae-Hyun, Park, Jung-Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243130/ https://www.ncbi.nlm.nih.gov/pubmed/34257795 http://dx.doi.org/10.1016/j.waojou.2021.100553 |
Ejemplares similares
-
Eperisone-Induced Anaphylaxis: Pharmacovigilance Data and Results of Allergy Testing
por: Park, Kyung Hee, et al.
Publicado: (2018) -
Delayed-Onset Anaphylaxis Caused by IgE Response to Influenza Vaccination
por: Kim, Min Jung, et al.
Publicado: (2019) -
Validation of an anti-α-Gal IgE fluoroenzyme-immunoassay for the screening of patients at risk of severe anaphylaxis to cetuximab
por: Serrier, Julien, et al.
Publicado: (2023) -
Animal Models of IgE Anaphylaxis
por: Gouel-Chéron, Aurélie, et al.
Publicado: (2023) -
IgE Cross-Reactivity between Humulus japonicus and Humulus lupulus
por: Jeong, Kyoung Yong, et al.
Publicado: (2018)